Skip to main content

Table 1 Demographic data, disease characteristics and treatments of the children survey participants

From: Psychometric evaluation of the Spanish version of the Pediatric Quality of Life Eosinophilic Esophagitis Questionnaire (Peds QL-EoE Module ™)

  

N = 350

%

Age Group

2–4 years

9

2.6

5–7 years

32

9.1

8–12 years

149

42.6

13–18 years

160

45.7

Sex

Male

256

73.1

Female

94

26.8

Symptoms at onset

Dysphagia

208

59.4

Food impaction

151

43.1

Abdominal pain

150

42.8

Nausea, vomiting, regurgitation

148

42.3

Heartburn

111

31.7

Food avoidance

94

26.8

Hoarseness

68

19.4

Chest pain

65

18.6

Weight loss

35

10

Hematemesis

5

1.4

Endoscopy incidental finding

13

3.7

Treatment

PPI

106

30.3

Corticosteroids

141

40.3

Diet

65

18.3

Othera

2

0.1

No treatment

36

10.3

  1. aOther: 1 Omalizumab; 1 Montelukast